{"id":744159,"date":"2026-06-18T09:17:09","date_gmt":"2026-06-18T09:17:09","guid":{"rendered":"https:\/\/www.newsbeep.com\/au\/744159\/"},"modified":"2026-06-18T09:17:09","modified_gmt":"2026-06-18T09:17:09","slug":"3-beaten-down-asx-healthcare-shares-tipped-to-rise-up-to-202","status":"publish","type":"post","link":"https:\/\/www.newsbeep.com\/au\/744159\/","title":{"rendered":"3 beaten-down ASX healthcare shares tipped to rise up to 202%"},"content":{"rendered":"\n

The ASX healthcare sector has been under immense pressure throughout the first half of 2026, as macroeconomic pressures, rising\u00a0inflation<\/a>, higher cost of living, and regulatory uncertainty have driven a sector-wide share price downturn.<\/p>\n

The S&P\/ASX 200 Health Care Index (ASX: XHJ) is the worst-performing sector by far in 2026 and has significantly underperformed the broader index. <\/p>\n

At the time of writing, the ASX 200 Health Care Index is down around 28% year to date and 42% from 12 months ago.<\/p>\n

For context, the wider S&P\/ASX 200 Index (ASX: XJO) is around 2.5% higher year to date and around 5% higher than this time last year. <\/p>\n

The good news is that analysts widely forecast many of these beaten-down ASX healthcare shares<\/a> to rebound over the next 12 months, with some carrying potential upside of up to 202%.<\/p>\n

Here are three of them.<\/p>\n

\"A<\/p>\n

Image source: Getty Images<\/p>\n

ResMed shares have fallen around another 4% at the time of writing on Thursday morning. For the year to date, the shares are down around 27%, and they’re roughly 32% lower than a year ago.\u00a0 <\/p>\n

The global leader in sleep health has been swept up in the general sector-wide ASX healthcare<\/a> sell-off. Its latest third-quarter earnings update didn’t help. The result came in softer than expected, forcing investor sentiment to keep tumbling.\u00a0 <\/p>\n

But it looks like the ASX healthcare stock is now oversold and trading far below fair value.\u00a0 <\/p>\n

Sleep disorders need long-term management, and as a global leader, ResMed has a powerful position in the large and growing market.\u00a0 <\/p>\n

According to Market Index data, the majority of brokers have a strong buy rating on ResMed shares and tip a huge 202% upside to an average target price of $80.09 at the time of writing.<\/p>\n

Pro Medicus Ltd (ASX: PME<\/a>) <\/p>\n

Pro Medicus shares have climbed higher in Thursday morning trade, up around 1% and changing hands at $170.72 a piece. For the year to date, however, the ASX healthcare shares are still down around 23% and around 38% lower than 12 months ago. <\/p>\n

The company’s share price turned a corner in early June when it announced three new contract wins. These include a new seven-year $16 million contract with TidalHealth, a five-year $28 million contract renewal with Allegheny Health Network (AHN), and a five-year $16 million contract renewal with OSU.<\/p>\n

The Pro Medicus share price has rebounded by over 29% since the 1st of June.<\/p>\n

The company’s US subsidiary also won two $40 million five-year contract renewals back in early March.\u00a0<\/p>\n

It looks like we’ll see more out of the company over the next 12 months, too. Market Index data shows that the majority of brokers rate the ASX healthcare shares as a strong buy and tip around a 13% upside to an average target price of $192.92 at the time of writing.<\/p>\n

Cochlear shares are climbing higher on Thursday. At the time of writing, the ASX healthcare company’s shares are up around 1% and changing hands at $112.30 a piece. But it’s been a difficult year for the medical hearing implant device company. Its shares are still down around 57% year to date and 60% lower than this time last year. <\/p>\n

Cochlear has also endured a sector-wide rotation away from ASX healthcare shares this year.<\/p>\n

Its share price has also crashed on two separate occasions in 2026. Once in February, off the back of a softer-than-expected half-year result. And again in April, when the company downgraded its FY26 earnings guidance<\/a>. Cochlear cited weaker conditions across developed markets and softer overall demand. The update was one of the worst earnings downgrades in the company’s listed history.\u00a0<\/p>\n

But Cochlear is still a strong, globally dominant business, and its long-term outlook is intact. I think the sell-off has been overdone. Market Index data suggests brokers are reserved about the stock. The majority rate Cochlear shares as a hold. But the $143.14 average target price still implies a potential 27% upside at the time of writing.<\/p>\n","protected":false},"excerpt":{"rendered":"The ASX healthcare sector has been under immense pressure throughout the first half of 2026, as macroeconomic pressures,…\n","protected":false},"author":2,"featured_media":411489,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[34],"tags":[64,63,137,500],"class_list":["post-744159","post","type-post","status-publish","format-standard","has-post-thumbnail","category-healthcare","tag-au","tag-australia","tag-health","tag-healthcare"],"_links":{"self":[{"href":"https:\/\/www.newsbeep.com\/au\/wp-json\/wp\/v2\/posts\/744159","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.newsbeep.com\/au\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.newsbeep.com\/au\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.newsbeep.com\/au\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.newsbeep.com\/au\/wp-json\/wp\/v2\/comments?post=744159"}],"version-history":[{"count":0,"href":"https:\/\/www.newsbeep.com\/au\/wp-json\/wp\/v2\/posts\/744159\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.newsbeep.com\/au\/wp-json\/wp\/v2\/media\/411489"}],"wp:attachment":[{"href":"https:\/\/www.newsbeep.com\/au\/wp-json\/wp\/v2\/media?parent=744159"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.newsbeep.com\/au\/wp-json\/wp\/v2\/categories?post=744159"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.newsbeep.com\/au\/wp-json\/wp\/v2\/tags?post=744159"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}